|
RTCD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.336200E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.463300E-03 |
| Normal-vs-Stage2 |
5.515000E-01 |
| Normal-vs-Stage3 |
2.898800E-01 |
| Normal-vs-Stage4 |
1.714420E-02 |
| Stage1-vs-Stage2 |
2.006400E-01 |
| Stage1-vs-Stage3 |
1.688630E-01 |
| Stage1-vs-Stage4 |
5.839400E-01 |
| Stage2-vs-Stage3 |
8.086800E-01 |
| Stage2-vs-Stage4 |
1.376230E-01 |
| Stage3-vs-Stage4 |
1.421980E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.974200E-02 |
| Normal-vs-AfricanAmerican |
2.814000E-02 |
| Normal-vs-Asian |
4.723000E-01 |
| Caucasian-vs-AfricanAmerican |
9.812000E-02 |
| Caucasian-vs-Asian |
4.660000E-01 |
| AfricanAmerican-vs-Asian |
5.551500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.005800E-01 |
| Normal-vs-Female |
1.029670E-02 |
| Male-vs-Female |
4.514200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.977100E-03 |
| Normal-vs-Age(41-60Yrs) |
2.173600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.304400E-02 |
| Normal-vs-Age(81-100Yrs) |
8.987800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.975500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.676600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.833000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.229400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.806800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.218400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.987600E-01 |
| Classical-VS-Follicular |
3.442800E-01 |
| Classical-VS-Other |
4.333400E-01 |
| Classical-VS-Normal |
2.612100E-02 |
| Tall-VS-Follicular |
8.651600E-01 |
| Tall-VS-Other |
2.601800E-01 |
| Tall-VS-Normal |
3.594100E-02 |
| Follicular-VS-Other |
4.069000E-01 |
| Follicular-VS-Normal |
2.364100E-02 |
| Other-VS-Normal |
9.573400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.489500E-02 |
| Normal-vs-N1 |
4.686400E-01 |
| N0-vs-N1 |
4.951600E-01 |
|
|
